8.59
-0.07
(-0.81%)
At close: January 31 at 5:35:52 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 1 | 6 | 6 |
| Avg. Estimate | 90.92M | 47.5M | 724.08M | 557.31M |
| Low Estimate | 83.3M | 47.5M | 673.9M | 227.92M |
| High Estimate | 103.6M | 47.5M | 931.25M | 1.03B |
| Year Ago Sales | 291.34M | 93.86M | 983.71M | 724.08M |
| Sales Growth (year/est) | -68.79% | -49.39% | -26.39% | -23.03% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NVV1.DE | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
| Reiterates | B. Riley Securities: Buy to Buy | 8/12/2024 |
| Maintains | JP Morgan: Underweight to Underweight | 8/12/2024 |
| Maintains | B. Riley Securities: Buy to Buy | 8/2/2024 |
Related Tickers
BIO3.DE Biotest Aktiengesellschaft
28.00
+2.19%
BIO.DE Biotest Aktiengesellschaft
41.40
0.00%
9VC.DE Atai Life Sciences N.V.
1.4955
+2.89%
T5O0.DE bioXXmed AG
0.9600
+10.85%
88Q.DE 4basebio PLC
14.00
+0.72%
PSH.DE Sernova Corp.
0.1447
+0.56%
7V0.DE Darwin AG
26.00
+0.78%
VX1.DE Vertex Pharmaceuticals Incorporated
445.25
+5.17%
AYJ.DE Valneva SE
2.7600
+11.29%
HPHA.DE Heidelberg Pharma AG
2.3900
-2.45%